Literature DB >> 9144478

CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19.

S Sato1, D A Steeber, P J Jansen, T F Tedder.   

Abstract

Establishing signal transduction thresholds that regulate B lymphocyte responses to foreign Ags and tolerance to self Ags is critical for humoral immune responses. The effects of altered signaling thresholds in B lymphocytes were examined in CD19-deficient mice and transgenic mice that expressed human CD19 at varying densities. Human CD19 restored normal B cell function and development to CD19-deficient mice when expressed at levels comparable to those of circulating human B cells. While CD19 expression levels were found to be developmentally regulated and tightly controlled in normal mice, two- or threefold changes in cell surface CD19 expression in transgenic mice dramatically affected B cell development, mitogen responses, serum Ig levels, humoral immune responses, and germinal center formation. B cells from mice that overexpressed CD19 also had decreased levels of surface IgM and a cell surface phenotype consistent with increased signaling in these cells. These results suggest that CD19 may serve similar functions in humans and mice and that CD19 defines signaling thresholds in vivo for the Ag receptor as well as other cell surface receptors that regulate B lymphocyte selection, activation, and differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144478

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes.

Authors:  G M Doody; D D Billadeau; E Clayton; A Hutchings; R Berland; S McAdam; P J Leibson; M Turner
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

2.  Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease.

Authors:  Norihito Yazawa; Yasuhito Hamaguchi; Jonathan C Poe; Thomas F Tedder
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

3.  Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner.

Authors:  Elizabeth O Lobo; Zhifang Zhang; John E Shively
Journal:  J Leukoc Biol       Date:  2009-05-19       Impact factor: 4.962

4.  CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody.

Authors:  Farrukh T Awan; Rosa Lapalombella; Rossana Trotta; Jonathan P Butchar; Bo Yu; Don M Benson; Julie M Roda; Carolyn Cheney; Xiaokui Mo; Amy Lehman; Jeffrey Jones; Joseph Flynn; David Jarjoura; John R Desjarlais; Susheela Tridandapani; Michael A Caligiuri; Natarajan Muthusamy; John C Byrd
Journal:  Blood       Date:  2009-12-02       Impact factor: 22.113

5.  Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice.

Authors:  E N Tsitsikov; J C Gutierrez-Ramos; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

6.  Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.

Authors:  Takashi Matsushita; Mayuka Horikawa; Yohei Iwata; Thomas F Tedder
Journal:  J Immunol       Date:  2010-07-12       Impact factor: 5.422

7.  A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice.

Authors:  Jonathan C Poe; Veronique Minard-Colin; Evgueni I Kountikov; Karen M Haas; Thomas F Tedder
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

8.  CD19 expression in B cells regulates atopic dermatitis in a mouse model.

Authors:  Koichi Yanaba; Masahiro Kamata; Yoshihide Asano; Yayoi Tada; Makoto Sugaya; Takafumi Kadono; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2013-04-12       Impact factor: 4.307

9.  Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells.

Authors:  Jamee C Nixon; Scott Ferrell; Cathrine Miner; Athenia L Oldham; Ute Hochgeschwender; Carol F Webb
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.

Authors:  Koichi Yanaba; Jean-David Bouaziz; Takashi Matsushita; Takeshi Tsubata; Thomas F Tedder
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.